The $15 billion ad-powered AI startup your doctor may already be using
OpenEvidence is booming despite questions about accuracy and ads.
TL;DR
- OpenEvidence, an AI-powered search engine, is being used by almost two-thirds of US doctors for patient decision-making.
- The startup has achieved a $15 billion valuation and processed over 42 million prompts last month.
- Doctors use the tool to search medical journals and guidelines for diagnosis and treatment.
- OpenEvidence faces competition from major AI companies like OpenAI and Anthropic.
- Concerns have been raised by researchers regarding the accuracy of the AI's results.
- The company has secured significant investment and plans to expand into drug discovery and clinical trials.
- Some studies indicate that OpenEvidence underperforms general-purpose AI models on clinical benchmarks.
- The company withdrew from the EU and UK due to the bloc's AI Act.